INTAS Develops COVID-19 Hyperimmune Globulin - A New Treatment

Tag archive for ‘INTAS Develops COVID-19 Hyperimmune Globulin – A New Treatment’

By editor3 On Thursday, August 27th, 2020

0 Comments

INTAS Develops COVID-19 Hyperimmune Globulin – A New Treatment

Ahmedabad, August 27, 2020. Intas Pharmaceuticals Ltd is a leading Pharmaceutical company from India. As per IQVIA (IMS), Intas is the 9th largest company in India having a strong presence in chronic therapeutic More...

Live Updates COVID-19 CASES

World 200,304,185

World

Confirmed: 200,304,185

Active: 15,480,826

Recovered: 180,563,692

Death: 4,259,667
USA 36,049,015

USA

Confirmed: 36,049,015

Active: 5,661,932

Recovered: 29,756,586

Death: 630,497
India 31,769,132

India

Confirmed: 31,769,132

Active: 410,321

Recovered: 30,933,022

Death: 425,789
Brazil 19,986,073

Brazil

Confirmed: 19,986,073

Active: 680,611

Recovered: 18,746,865

Death: 558,597
France 6,178,632

France

Confirmed: 6,178,632

Active: 348,908

Recovered: 5,717,731

Death: 111,993
Italy 4,363,374

Italy

Confirmed: 4,363,374

Active: 94,216

Recovered: 4,141,043

Death: 128,115
Germany 3,782,326

Germany

Confirmed: 3,782,326

Active: 30,218

Recovered: 3,659,900

Death: 92,208
Bangladesh 1,296,093

Bangladesh

Confirmed: 1,296,093

Active: 149,651

Recovered: 1,125,045

Death: 21,397
Pakistan 1,047,999

Pakistan

Confirmed: 1,047,999

Active: 78,595

Recovered: 945,829

Death: 23,575
Sri Lanka 316,219

Sri Lanka

Confirmed: 316,219

Active: 28,804

Recovered: 282,770

Death: 4,645
Afghanistan 148,933

Afghanistan

Confirmed: 148,933

Active: 41,201

Recovered: 100,896

Death: 6,836
China 93,289

China

Confirmed: 93,289

Active: 1,240

Recovered: 87,413

Death: 4,636